These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22566118)

  • 21. Patients with progressive multiple sclerosis have elevated antibodies to neurofilament subunit.
    Silber E; Semra YK; Gregson NA; Sharief MK
    Neurology; 2002 May; 58(9):1372-81. PubMed ID: 12011283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
    Kuhle J; Barro C; Andreasson U; Derfuss T; Lindberg R; Sandelius Å; Liman V; Norgren N; Blennow K; Zetterberg H
    Clin Chem Lab Med; 2016 Oct; 54(10):1655-61. PubMed ID: 27071153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of polyclonal anti-GM1 IgM and anti-neurofilament antibodies with CSF oligoclonal bands in a young with amyotrophic lateral sclerosis.
    Annunziata P; Maimone D; Guazzi GC
    Acta Neurol Scand; 1995 Nov; 92(5):387-93. PubMed ID: 8610492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
    Novakova L; Zetterberg H; Sundström P; Axelsson M; Khademi M; Gunnarsson M; Malmeström C; Svenningsson A; Olsson T; Piehl F; Blennow K; Lycke J
    Neurology; 2017 Nov; 89(22):2230-2237. PubMed ID: 29079686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of peptides binding to IgG in the CSF of multiple sclerosis patients.
    Cortese I; Capone S; Tafi R; Grimaldi LM; Nicosia A; Cortese R
    Mult Scler; 1998 Feb; 4(1):31-6. PubMed ID: 9532590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cerebrospinal fluid antibodies to tubulin are elevated in the patients with multiple sclerosis.
    Svarcová J; Fialová L; Bartos A; Steinbachová M; Malbohan I
    Eur J Neurol; 2008 Nov; 15(11):1173-9. PubMed ID: 18973612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease.
    Peng L; Bi C; Xia D; Mao L; Qian H
    Mult Scler Relat Disord; 2019 May; 30():123-128. PubMed ID: 30771578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.
    Xiao BG; Linington C; Link H
    J Neuroimmunol; 1991 Feb; 31(2):91-6. PubMed ID: 1991822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergy of serum and cerebrospinal fluid antibodies against axonal cytoskeletal proteins in patients with different neurological diseases.
    Fialová L; Bartos A; Soukupová J; Svarcová J; Ridzon P; Malbohan I
    Folia Biol (Praha); 2009; 55(1):23-6. PubMed ID: 19445843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.
    Parkhomenko TA; Doronin VB; Castellazzi M; Padroni M; Pastore M; Buneva VN; Granieri E; Nevinsky GA
    PLoS One; 2014; 9(4):e93001. PubMed ID: 24736683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
    Villar LM; Picón C; Costa-Frossard L; Alenda R; García-Caldentey J; Espiño M; Muriel A; Álvarez-Cermeño JC
    Eur J Neurol; 2015 Aug; 22(8):1169-75. PubMed ID: 25324032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
    Kuhle J; Malmeström C; Axelsson M; Plattner K; Yaldizli O; Derfuss T; Giovannoni G; Kappos L; Lycke J
    Acta Neurol Scand; 2013 Dec; 128(6):e33-6. PubMed ID: 23763388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Virus antibodies in the cerebrospinal fluid of multiple sclerosis patients detected with ELISA tests.
    Leinikki P; Shekarchi I; Iivanainen M; Taskinen E; Holmes KV; Madden D; Sever JL
    J Neurol Sci; 1982 Dec; 57(2-3):249-55. PubMed ID: 6298370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optic neuritis and multiple sclerosis: anti-MBP and anti-MBP peptide antibody-secreting cells are accumulated in CSF.
    Söderström M; Link H; Xu Z; Fredriksson S
    Neurology; 1993 Jun; 43(6):1215-22. PubMed ID: 7513391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoblot detection of oligoclonal anti-myelin basic protein IgG antibodies in cerebrospinal fluid in multiple sclerosis.
    Cruz M; Olsson T; Ernerudh J; Höjeberg B; Link H
    Neurology; 1987 Sep; 37(9):1515-9. PubMed ID: 2442667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective associations of apolipoproteins A-I and A-II with neurofilament levels in early multiple sclerosis.
    McComb M; Krikheli M; Uher T; Browne RW; Srpova B; Oechtering J; Maceski AM; Tyblova M; Jakimovski D; Ramasamy DP; Bergsland N; Krasensky J; Noskova L; Fialova L; Weinstock-Guttman B; Havrdova EK; Vaneckova M; Zivadinov R; Horakova D; Kuhle J; Ramanathan M
    J Clin Lipidol; 2020; 14(5):675-684.e2. PubMed ID: 32758395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid.
    Kneitz RH; Schubert J; Tollmann F; Zens W; Hedman K; Weissbrich B
    BMC Infect Dis; 2004 Sep; 4():33. PubMed ID: 15355548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avidity of anti-phospholipid antibodies in relation to their levels.
    FialovÁ L; KuchaŘ O; PetrÁČkovÁ M; Malbohan I; Zima T
    Cent Eur J Immunol; 2020; 45(2):136-143. PubMed ID: 33456323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.